Société Adial Pharmaceuticals, Inc.
Actions
ADIL
US00688A2050
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,7 USD | +0,59 % | -.--% | -8,60 % |
Métier
Nombre d'employés: 6
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Bankole Johnson
FOU | Founder | 64 | 01/11/10 |
Cary Claiborne
CEO | Chief Executive Officer | 64 | 02/11/21 |
Joseph Truluck
DFI | Director of Finance/CFO | 46 | 01/05/16 |
Chief Tech/Sci/R&D Officer | - | - | |
Tony Goodman
COO | Chief Operating Officer | 60 | 01/07/17 |
General Counsel | - | - | |
Comptroller/Controller/Auditor | - | - | |
Mark H. Peikin
PRN | Corporate Officer/Principal | - | 01/10/19 |
Alex Lugovoy
PRN | Corporate Officer/Principal | - | 11/04/19 |
Schuyler Vinzant
PRN | Corporate Officer/Principal | - | 01/01/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jack W. Reich
LAW | General Counsel | - | 19/05/20 |
Cary Claiborne
CEO | Chief Executive Officer | 64 | 02/11/21 |
Tony Goodman
COO | Chief Operating Officer | 60 | 01/07/17 |
J. Anderson
BRD | Director/Board Member | 74 | 01/02/15 |
Director/Board Member | 44 | 01/09/14 | |
Bankole Johnson
FOU | Founder | 64 | 01/11/10 |
James Newman
BRD | Director/Board Member | 81 | 01/09/14 |
Kevin Schuyler
CHM | Chairman | 55 | 01/04/16 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 4 054 861 | 3 891 107 ( 95,96 %) | 0 | 95,96 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-8,60 % | 6,89 M | |
-3,46 % | 102 Md | |
+1,41 % | 96,09 Md | |
+2,13 % | 22,28 Md | |
-15,84 % | 21,4 Md | |
-10,07 % | 18,14 Md | |
-39,98 % | 17,02 Md | |
-14,65 % | 16,09 Md | |
+4,39 % | 13,83 Md | |
+31,35 % | 11,97 Md |
- Bourse
- Actions
- Action ADIL
- Société Adial Pharmaceuticals, Inc.